GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellid Co Ltd (XKRX:299660) » Definitions » Deferred Policy Acquisition Costs

Cellid Co (XKRX:299660) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is Cellid Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Cellid Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 142 Suite 504, Korea Seoul National University Building, seoul, KOR, 08826
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.